A. Gencer Et Al. , "Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection: a trigger for asthma?," JOURNAL OF ASTHMA , vol.60, no.6, pp.1221-1226, 2023
Gencer, A. Et Al. 2023. Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection: a trigger for asthma?. JOURNAL OF ASTHMA , vol.60, no.6 , 1221-1226.
Gencer, A., Ozturk, B. C., BÖREKÇİ, Ş., & GEMİCİOĞLU, B., (2023). Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection: a trigger for asthma?. JOURNAL OF ASTHMA , vol.60, no.6, 1221-1226.
Gencer, Aysegul Et Al. "Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection: a trigger for asthma?," JOURNAL OF ASTHMA , vol.60, no.6, 1221-1226, 2023
Gencer, Aysegul Et Al. "Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection: a trigger for asthma?." JOURNAL OF ASTHMA , vol.60, no.6, pp.1221-1226, 2023
Gencer, A. Et Al. (2023) . "Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection: a trigger for asthma?." JOURNAL OF ASTHMA , vol.60, no.6, pp.1221-1226.
@article{article, author={Aysegul Gencer Et Al. }, title={Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection: a trigger for asthma?}, journal={JOURNAL OF ASTHMA}, year=2023, pages={1221-1226} }